A Randomized Trial of Thymoglobulin to Prevent Chronic ... - CBMTG
A Randomized Trial of Thymoglobulin to Prevent Chronic ... - CBMTG
A Randomized Trial of Thymoglobulin to Prevent Chronic ... - CBMTG
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Inclusion Criteria1. The recipient is aged between 16 and 702. The recipient has an hema<strong>to</strong>logic malignancy3. The recipient will receive either a bone marrow (“HPC, Marrow”) orblood progeni<strong>to</strong>r cell (“HPC, Apheresis”) graft4. The preparative regimen may be MAbl, NMAbl, or RIC5. The recipient has an unrelated donor who with high resolution typing iseither fully MHC matched at HLA-A, B, C and DRB1 with the recipient oris 1-antigen or 1–allele mismatched at A, B, C or DRB1 loci
Change language